Lactiga is heading to the American Academy of Allergy, Asthma and Immunology - AAAAI 2025 Conference from Feb 28 - March 03rd! We’re excited to present a poster on our recent scientific findings on our secretory IgA program, and its antiviral efficacy against SARS-CoV-2 in vivo. We can't wait to connect with immunologists and healthcare providers who share our passion for groundbreaking science in mucosal immunity. Let's meet up! Email us at [email protected] to connect and grab a coffee. See you there!
Lactiga
生物技术研究
North Brunswick，New Jersey 991 位关注者
Creating the future of anti-infective therapeutics by unlocking the immunologic properties of human milk
关于我们
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including SARS-CoV-2. Lactiga has earned awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.
- 网站
-
https://www.lactiga.com
Lactiga的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- North Brunswick，New Jersey
- 类型
- 私人持股
- 创立
- 2017
地点
Lactiga员工
-
Rikin M.
-
Abhishek (Abhi) Dabral
Clinical Data Science Leader & Head, Clinical Data Management | Digital Health Technologies | Drug Development & Regulatory Submissions | HBR…
-
Leann M. Pinto
Experienced pharma patent litigator and tech industry executive focused on harnessing the power of innovation to build the next big thing.
-
Ani Khachatrian
Student at University of Toronto
动态
-
Grateful that the recent Executive Orders did not impact such an important event—FDA-NIH Rare Disease Day 2025. As the developers of LCTG-001, which holds Rare Pediatric Disease Designation, we at Lactiga are committed to advancing research and regulatory support for rare disease patients. Looking forward to connecting with like-minded individuals dedicated to driving innovation and improving patient outcomes. See you there!
-
-
Breaking news! Our research team has secured a multi-million dollar, multi-year grant from The National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) to advance our innovative mucosal-targeted secretory IgA therapy for immunodeficient patients. This funding supports our mission to develop mucosal-targeted secretory IgA therapy, a potential game-changer for adults and children with Common Variable Immune Deficiency (CVID); a rare disease where mortality rates are higher in children due to compromised immune systems. A special thank you to our collaborators, Center for Discovery and Innovation and Kenox Pharmaceuticals, Inc. Immune Deficiency Foundation Learn more here: https://lnkd.in/eYbtJrqA
-
Lactiga's CEO and Co-founder, Rikin Mehta, will be in San Francisco during J.P. Morgan's Healthcare Conference week from January 13 - 15, 2025, attending key industry events and engaging with life sciences executives and investors. As the new administration takes shape and policy priorities evolve, improving health outcomes for children and vulnerable populations remains a critical focus for us. At Lactiga, we're whiteboarding the future of human immunity with our platform technology, leveraging secretory IgA antibodies from breastmilk to tackle unmet medical needs. Learn more about our lead candidate, LCTG-001, and its transformative potential in patients with Common Variable Immunodeficiency. Let's connect during #JPM2025!
-
-
Listen to Lactiga's CSO, Viraj Mane, PhD, discuss his entrepreneurial journey!
??The first episode of "What Do You Do" with Viraj Mane, PhD, Co-Founder of Lactiga, is live! Get inspired by his biotech journey and expert advice. ??Full Episode Here: https://lnkd.in/eySKaRU3 ???Listen in and be inspired! #Podcast #BiotechInnovation #Entrepreneurship #whatdoyoudo #jobadvice #recruiter #lifesciences #whatdoyoudo
-
Rock Star Alert ?? ! It’s been a pleasure having Camila on the Lactiga team this summer! As an engineering student, she brought incredible dedication, creative thinking and problem-solving skills in building our supply chain. Her hard work and passion for our mission made a real impact on our efforts to advance relationships with breastmilk centers across America. We are grateful for her contributions and excited to see where her career takes her next!??
Reflecting on my summer internship at Lactiga, I am incredibly thankful for the opportunity to work alongside such a supportive team. A special thank you to Rikin M. and Viraj Mane, PhD, for making this experience one that I will always cherish and for being such inspiring mentors. This internship not only immersed me in the world of ?biotherapeutics and engineering but also allowed me to continue my passion for supporting new moms on their lactation journey and explore engineering solutions that benefit a broader community. I’m inspired by what I’ve learned and can’t wait to see how I can make an impact in the industry moving forward.
-
Lactiga is thrilled to attend the Immunodeficiency Foundation Conference 2024! This incredible event brings together leading experts, researchers, and advocates in the field of immunodeficiency. If you're attending, meet with Lactiga CEO Rikin Mehta to discuss how we can collaborate and drive progress in immunodeficiency research. https://lnkd.in/dNtQgMTr #ImmunodeficiencyFoundation #IDF2024 #HealthcareInnovation #Immunology #ProfessionalDevelopment #Networking
-
-
Building a biotech company truly takes a village, and we are fortunate to have exceptional partners who go above and beyond the call of duty. Today, I want to highlight and express our appreciation to Wishup.co! They are more than just a vendor; they have been a strategic business partner whose Virtual Assistants have been instrumental in our journey. Thank you to the Wishup.co team, for playing a crucial role in helping build our village. Special shout out to: Vaashee Singh Neelesh Rangwani #Biotech #Innovation #Partnership #ThankYou
-
A giant congrats to BioNJ for an incredible BioPartnering conference in Jersey City, #NewJersey. And of course, a major Thank You for giving our CEO Rikin M. the opportunity to present! #biotechnology #pharmaceuticals
-